Contact Person : Carlotta McKee; Last Date for the submission of abstract : 29/08/2008; Description : AD is a neurodegenerative disease with large
unmet needs for preventing or slowing both its
onset and progression. Attemps to fill these
gaps in treatment present clinical/regulatory
challenges.